SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-056425
Filing Date
2023-11-22
Accepted
2023-11-22 13:47:57
Documents
1
Period of Report
2023-11-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10224
  Complete submission text file 0001209191-23-056425.txt   11638
Mailing Address 99 HAYDEN AVENUE BUILDING B, SUITE 450 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE BUILDING B, SUITE 450 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Issuer) CIK: 0001662244 (see all company filings)

IRS No.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 733 CONCORD AVENUE C/O WAVE LIFE SCIENCES USA, INC. CAMBRIDGE MA 02138
Business Address
Gaiero David G (Reporting) CIK: 0001799784 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40499 | Film No.: 231432552